HCA
$493.88-5.77 (-1.15%)
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intens...
Recent News
Jim Cramer on HCA Healthcare: “I Want You to Buy It Only in Big Clumps”
HCA Healthcare, Inc. (NYSE:HCA) is one of the stocks mentioned during the show, as we cover everything Jim Cramer said about the market. Inquiring about the stock, a caller pointed out that the company is the “largest hospital operator,” benefits from an aging population, and has accelerating EPS. Cramer replied: We have liked HCA for […]
2 Stocks That Could Create Lasting Generational Wealth
These investments could help you sleep peacefully at night.
HCA Stock: How Probing Positions Help Patient Investors In Sideways Market
As individual investors, we have the option to go entirely in cash if we so desire. Institutional investors — think big mutual funds — don't have that luxury. As a hospital stock, HCA Healthcare fits the bill.
HCA Healthcare (HCA): 3 Reasons We Love This Stock
Since March 2021, the S&P 500 has delivered a total return of 70.6%. But one standout stock has more than doubled the market - over the past five years, HCA Healthcare has surged 178% to $533.14 per share. Its momentum hasn’t stopped as it’s also gained 32.2% in the last six months, beating the S&P by 29.9%.
How The HCA Healthcare (HCA) Narrative Is Shifting Around AI, Medicaid Support And Valuation
HCA Healthcare’s modeled fair value has been nudged higher from about US$541.52 to about US$543.05, signaling only a very modest adjustment to the price target range. Behind that small move, recent analyst commentary has focused on potential earnings support from Georgia’s Medicaid SDP approval and ongoing AI and efficiency efforts, while also flagging reimbursement and legislative risks that could limit how far targets stretch. As you read on, you will see how these moving pieces shape the...